Loading…
Comparison of the Efficacy of Homologous and Autologous Platelet-Rich Plasma (PRP) for Treating Androgenic Alopecia
Background Androgenetic alopecia (AGA), the most common cause of hair loss in both sexes, accounts for 95% of all cases of hair loss. Although the literature has suggested that both nonactivated (n-PRP) and activated autologous (a-PRP) PRP can be used to treat AGA, we did not find any study investig...
Saved in:
Published in: | Aesthetic plastic surgery 2018-02, Vol.42 (1), p.297-303 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c372t-1ef240061205c442dc5433919e0c0473ecedbb1101d588b6a85f5feed34ae6d23 |
---|---|
cites | cdi_FETCH-LOGICAL-c372t-1ef240061205c442dc5433919e0c0473ecedbb1101d588b6a85f5feed34ae6d23 |
container_end_page | 303 |
container_issue | 1 |
container_start_page | 297 |
container_title | Aesthetic plastic surgery |
container_volume | 42 |
creator | Ince, Bilsev Yildirim, Mehmet Emin Cem Dadaci, Mehmet Avunduk, Mustafa Cihat Savaci, Nedim |
description | Background
Androgenetic alopecia (AGA), the most common cause of hair loss in both sexes, accounts for 95% of all cases of hair loss. Although the literature has suggested that both nonactivated (n-PRP) and activated autologous (a-PRP) PRP can be used to treat AGA, we did not find any study investigating the use of homologous PRP (h-PRP) for this purpose. Also, to the best of our knowledge, there are no studies comparing the efficacy of h-PRP, a-PRP, or n-PRP on AGA therapy.
Objectives
The aim of this study was to compare the increase in hair density, average number of platelets, complications, preparation, and duration of application in the treatment of AGA using a-PRP, n-PRP, and h-PRP.
Methods
Between 2014 and 2015, we studied male patients who had experienced increased hair loss in the last year. Patients were divided into three groups: Group 1 received n-PRP, Group 2 received active PRP, and Group 3 received h-PRP. For Group 1, PRP was prepared by a single centrifugation prepared from the patient’s own blood. For Group 2, the PRP was prepared from the patient’s own blood, but a second centrifugation was applied for platelet activation with calcium chloride. For Group 3, the PRP was prepared from pooled platelets with the same blood group as the patient from the blood center. PRP was injected at 1, 2, and 6 months. The hair density (n/cm
2
) of each patient before and after injection was calculated. Each patient was assigned a fixed evaluation point at the time of application to calculate hair density.
Results
At 2, 6, and 12 months after the first treatment, the increase in hair density was calculated as 11.2, 26.1, and 32.4%, respectively, in Group 1; 8.1, 12.5, and 20.8%, respectively, in Group 2; and 16.09, 36.41, and 41.76%, respectively, in Group 3. The increase in hair density was statistically significantly greater in Group 1 than in Group 2 and more so in Group 3 than in both groups among all controls (
p
|
doi_str_mv | 10.1007/s00266-017-1004-y |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1960925676</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1993458789</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-1ef240061205c442dc5433919e0c0473ecedbb1101d588b6a85f5feed34ae6d23</originalsourceid><addsrcrecordid>eNp1kc1KJDEUhcOgjK0zDzCbIeBGF9Gbn0qqlk3jHwg24sDsinTqpi2pqvQkVYt-e9O0yiC4Ch_57kkuh5BfHC44gLlMAEJrBtywzIptv5EZV1KwQih-QGYgtWKC679H5DilFwAujFHfyZGoOGTRzEhahH5jY5vCQIOn4zPSK-9bZ912x7ehD11YhylROzR0Po3vuOzsiB2O7LF1zztKvaVny8flOfUh0qeIdmyHNZ0PTQxrHFpH513YoGvtD3LobZfw59t5Qv5cXz0tbtn9w83dYn7PnDRiZBy9UACaCyicUqJxhZKy4hWCA2UkOmxWK543aYqyXGlbFr7wiI1UFnUj5Ak52-duYvg3YRrrvk0Ou84OmFeoeaWhEoU2Oqunn9SXMMUh_y5blVRFacoqW3xvuRhSiujrTWx7G7c1h3rXSL1vpM6N7FjV2zzz-y15WvXYfEy8V5AFsRdSvhrWGP97-svUV5cclg4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1993458789</pqid></control><display><type>article</type><title>Comparison of the Efficacy of Homologous and Autologous Platelet-Rich Plasma (PRP) for Treating Androgenic Alopecia</title><source>Springer Nature</source><creator>Ince, Bilsev ; Yildirim, Mehmet Emin Cem ; Dadaci, Mehmet ; Avunduk, Mustafa Cihat ; Savaci, Nedim</creator><creatorcontrib>Ince, Bilsev ; Yildirim, Mehmet Emin Cem ; Dadaci, Mehmet ; Avunduk, Mustafa Cihat ; Savaci, Nedim</creatorcontrib><description>Background
Androgenetic alopecia (AGA), the most common cause of hair loss in both sexes, accounts for 95% of all cases of hair loss. Although the literature has suggested that both nonactivated (n-PRP) and activated autologous (a-PRP) PRP can be used to treat AGA, we did not find any study investigating the use of homologous PRP (h-PRP) for this purpose. Also, to the best of our knowledge, there are no studies comparing the efficacy of h-PRP, a-PRP, or n-PRP on AGA therapy.
Objectives
The aim of this study was to compare the increase in hair density, average number of platelets, complications, preparation, and duration of application in the treatment of AGA using a-PRP, n-PRP, and h-PRP.
Methods
Between 2014 and 2015, we studied male patients who had experienced increased hair loss in the last year. Patients were divided into three groups: Group 1 received n-PRP, Group 2 received active PRP, and Group 3 received h-PRP. For Group 1, PRP was prepared by a single centrifugation prepared from the patient’s own blood. For Group 2, the PRP was prepared from the patient’s own blood, but a second centrifugation was applied for platelet activation with calcium chloride. For Group 3, the PRP was prepared from pooled platelets with the same blood group as the patient from the blood center. PRP was injected at 1, 2, and 6 months. The hair density (n/cm
2
) of each patient before and after injection was calculated. Each patient was assigned a fixed evaluation point at the time of application to calculate hair density.
Results
At 2, 6, and 12 months after the first treatment, the increase in hair density was calculated as 11.2, 26.1, and 32.4%, respectively, in Group 1; 8.1, 12.5, and 20.8%, respectively, in Group 2; and 16.09, 36.41, and 41.76%, respectively, in Group 3. The increase in hair density was statistically significantly greater in Group 1 than in Group 2 and more so in Group 3 than in both groups among all controls (
p
< 0.05).
Conclusion
The efficacy of both PRPs was determined in AGA treatment in our study. However, it was determined statistically that the increase in hair density with h-PRP was greater than with autologous PRP groups. We believe that h-PRP therapy can be used in patients with AGA presenting with hair loss.
Level of Evidence II
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors
www.springer.com/00266
.</description><identifier>ISSN: 0364-216X</identifier><identifier>EISSN: 1432-5241</identifier><identifier>DOI: 10.1007/s00266-017-1004-y</identifier><identifier>PMID: 29101437</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adult ; Alopecia - diagnosis ; Alopecia - therapy ; Baldness ; Cohort Studies ; Hair - growth & development ; Hair loss ; Humans ; Injections, Intralesional ; Male ; Medicine ; Medicine & Public Health ; Original Article ; Otorhinolaryngology ; Patients ; Plastic Surgery ; Platelet-Rich Plasma ; Prospective Studies ; Sensitivity and Specificity ; Transplantation, Autologous - methods ; Transplantation, Homologous - methods</subject><ispartof>Aesthetic plastic surgery, 2018-02, Vol.42 (1), p.297-303</ispartof><rights>Springer Science+Business Media, LLC and International Society of Aesthetic Plastic Surgery 2017</rights><rights>Aesthetic Plastic Surgery is a copyright of Springer, (2017). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-1ef240061205c442dc5433919e0c0473ecedbb1101d588b6a85f5feed34ae6d23</citedby><cites>FETCH-LOGICAL-c372t-1ef240061205c442dc5433919e0c0473ecedbb1101d588b6a85f5feed34ae6d23</cites><orcidid>0000-0002-1756-4131</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29101437$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ince, Bilsev</creatorcontrib><creatorcontrib>Yildirim, Mehmet Emin Cem</creatorcontrib><creatorcontrib>Dadaci, Mehmet</creatorcontrib><creatorcontrib>Avunduk, Mustafa Cihat</creatorcontrib><creatorcontrib>Savaci, Nedim</creatorcontrib><title>Comparison of the Efficacy of Homologous and Autologous Platelet-Rich Plasma (PRP) for Treating Androgenic Alopecia</title><title>Aesthetic plastic surgery</title><addtitle>Aesth Plast Surg</addtitle><addtitle>Aesthetic Plast Surg</addtitle><description>Background
Androgenetic alopecia (AGA), the most common cause of hair loss in both sexes, accounts for 95% of all cases of hair loss. Although the literature has suggested that both nonactivated (n-PRP) and activated autologous (a-PRP) PRP can be used to treat AGA, we did not find any study investigating the use of homologous PRP (h-PRP) for this purpose. Also, to the best of our knowledge, there are no studies comparing the efficacy of h-PRP, a-PRP, or n-PRP on AGA therapy.
Objectives
The aim of this study was to compare the increase in hair density, average number of platelets, complications, preparation, and duration of application in the treatment of AGA using a-PRP, n-PRP, and h-PRP.
Methods
Between 2014 and 2015, we studied male patients who had experienced increased hair loss in the last year. Patients were divided into three groups: Group 1 received n-PRP, Group 2 received active PRP, and Group 3 received h-PRP. For Group 1, PRP was prepared by a single centrifugation prepared from the patient’s own blood. For Group 2, the PRP was prepared from the patient’s own blood, but a second centrifugation was applied for platelet activation with calcium chloride. For Group 3, the PRP was prepared from pooled platelets with the same blood group as the patient from the blood center. PRP was injected at 1, 2, and 6 months. The hair density (n/cm
2
) of each patient before and after injection was calculated. Each patient was assigned a fixed evaluation point at the time of application to calculate hair density.
Results
At 2, 6, and 12 months after the first treatment, the increase in hair density was calculated as 11.2, 26.1, and 32.4%, respectively, in Group 1; 8.1, 12.5, and 20.8%, respectively, in Group 2; and 16.09, 36.41, and 41.76%, respectively, in Group 3. The increase in hair density was statistically significantly greater in Group 1 than in Group 2 and more so in Group 3 than in both groups among all controls (
p
< 0.05).
Conclusion
The efficacy of both PRPs was determined in AGA treatment in our study. However, it was determined statistically that the increase in hair density with h-PRP was greater than with autologous PRP groups. We believe that h-PRP therapy can be used in patients with AGA presenting with hair loss.
Level of Evidence II
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors
www.springer.com/00266
.</description><subject>Adult</subject><subject>Alopecia - diagnosis</subject><subject>Alopecia - therapy</subject><subject>Baldness</subject><subject>Cohort Studies</subject><subject>Hair - growth & development</subject><subject>Hair loss</subject><subject>Humans</subject><subject>Injections, Intralesional</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Original Article</subject><subject>Otorhinolaryngology</subject><subject>Patients</subject><subject>Plastic Surgery</subject><subject>Platelet-Rich Plasma</subject><subject>Prospective Studies</subject><subject>Sensitivity and Specificity</subject><subject>Transplantation, Autologous - methods</subject><subject>Transplantation, Homologous - methods</subject><issn>0364-216X</issn><issn>1432-5241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kc1KJDEUhcOgjK0zDzCbIeBGF9Gbn0qqlk3jHwg24sDsinTqpi2pqvQkVYt-e9O0yiC4Ch_57kkuh5BfHC44gLlMAEJrBtywzIptv5EZV1KwQih-QGYgtWKC679H5DilFwAujFHfyZGoOGTRzEhahH5jY5vCQIOn4zPSK-9bZ912x7ehD11YhylROzR0Po3vuOzsiB2O7LF1zztKvaVny8flOfUh0qeIdmyHNZ0PTQxrHFpH513YoGvtD3LobZfw59t5Qv5cXz0tbtn9w83dYn7PnDRiZBy9UACaCyicUqJxhZKy4hWCA2UkOmxWK543aYqyXGlbFr7wiI1UFnUj5Ak52-duYvg3YRrrvk0Ou84OmFeoeaWhEoU2Oqunn9SXMMUh_y5blVRFacoqW3xvuRhSiujrTWx7G7c1h3rXSL1vpM6N7FjV2zzz-y15WvXYfEy8V5AFsRdSvhrWGP97-svUV5cclg4</recordid><startdate>20180201</startdate><enddate>20180201</enddate><creator>Ince, Bilsev</creator><creator>Yildirim, Mehmet Emin Cem</creator><creator>Dadaci, Mehmet</creator><creator>Avunduk, Mustafa Cihat</creator><creator>Savaci, Nedim</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1756-4131</orcidid></search><sort><creationdate>20180201</creationdate><title>Comparison of the Efficacy of Homologous and Autologous Platelet-Rich Plasma (PRP) for Treating Androgenic Alopecia</title><author>Ince, Bilsev ; Yildirim, Mehmet Emin Cem ; Dadaci, Mehmet ; Avunduk, Mustafa Cihat ; Savaci, Nedim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-1ef240061205c442dc5433919e0c0473ecedbb1101d588b6a85f5feed34ae6d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>Alopecia - diagnosis</topic><topic>Alopecia - therapy</topic><topic>Baldness</topic><topic>Cohort Studies</topic><topic>Hair - growth & development</topic><topic>Hair loss</topic><topic>Humans</topic><topic>Injections, Intralesional</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Original Article</topic><topic>Otorhinolaryngology</topic><topic>Patients</topic><topic>Plastic Surgery</topic><topic>Platelet-Rich Plasma</topic><topic>Prospective Studies</topic><topic>Sensitivity and Specificity</topic><topic>Transplantation, Autologous - methods</topic><topic>Transplantation, Homologous - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ince, Bilsev</creatorcontrib><creatorcontrib>Yildirim, Mehmet Emin Cem</creatorcontrib><creatorcontrib>Dadaci, Mehmet</creatorcontrib><creatorcontrib>Avunduk, Mustafa Cihat</creatorcontrib><creatorcontrib>Savaci, Nedim</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Aesthetic plastic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ince, Bilsev</au><au>Yildirim, Mehmet Emin Cem</au><au>Dadaci, Mehmet</au><au>Avunduk, Mustafa Cihat</au><au>Savaci, Nedim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of the Efficacy of Homologous and Autologous Platelet-Rich Plasma (PRP) for Treating Androgenic Alopecia</atitle><jtitle>Aesthetic plastic surgery</jtitle><stitle>Aesth Plast Surg</stitle><addtitle>Aesthetic Plast Surg</addtitle><date>2018-02-01</date><risdate>2018</risdate><volume>42</volume><issue>1</issue><spage>297</spage><epage>303</epage><pages>297-303</pages><issn>0364-216X</issn><eissn>1432-5241</eissn><abstract>Background
Androgenetic alopecia (AGA), the most common cause of hair loss in both sexes, accounts for 95% of all cases of hair loss. Although the literature has suggested that both nonactivated (n-PRP) and activated autologous (a-PRP) PRP can be used to treat AGA, we did not find any study investigating the use of homologous PRP (h-PRP) for this purpose. Also, to the best of our knowledge, there are no studies comparing the efficacy of h-PRP, a-PRP, or n-PRP on AGA therapy.
Objectives
The aim of this study was to compare the increase in hair density, average number of platelets, complications, preparation, and duration of application in the treatment of AGA using a-PRP, n-PRP, and h-PRP.
Methods
Between 2014 and 2015, we studied male patients who had experienced increased hair loss in the last year. Patients were divided into three groups: Group 1 received n-PRP, Group 2 received active PRP, and Group 3 received h-PRP. For Group 1, PRP was prepared by a single centrifugation prepared from the patient’s own blood. For Group 2, the PRP was prepared from the patient’s own blood, but a second centrifugation was applied for platelet activation with calcium chloride. For Group 3, the PRP was prepared from pooled platelets with the same blood group as the patient from the blood center. PRP was injected at 1, 2, and 6 months. The hair density (n/cm
2
) of each patient before and after injection was calculated. Each patient was assigned a fixed evaluation point at the time of application to calculate hair density.
Results
At 2, 6, and 12 months after the first treatment, the increase in hair density was calculated as 11.2, 26.1, and 32.4%, respectively, in Group 1; 8.1, 12.5, and 20.8%, respectively, in Group 2; and 16.09, 36.41, and 41.76%, respectively, in Group 3. The increase in hair density was statistically significantly greater in Group 1 than in Group 2 and more so in Group 3 than in both groups among all controls (
p
< 0.05).
Conclusion
The efficacy of both PRPs was determined in AGA treatment in our study. However, it was determined statistically that the increase in hair density with h-PRP was greater than with autologous PRP groups. We believe that h-PRP therapy can be used in patients with AGA presenting with hair loss.
Level of Evidence II
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors
www.springer.com/00266
.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>29101437</pmid><doi>10.1007/s00266-017-1004-y</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-1756-4131</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0364-216X |
ispartof | Aesthetic plastic surgery, 2018-02, Vol.42 (1), p.297-303 |
issn | 0364-216X 1432-5241 |
language | eng |
recordid | cdi_proquest_miscellaneous_1960925676 |
source | Springer Nature |
subjects | Adult Alopecia - diagnosis Alopecia - therapy Baldness Cohort Studies Hair - growth & development Hair loss Humans Injections, Intralesional Male Medicine Medicine & Public Health Original Article Otorhinolaryngology Patients Plastic Surgery Platelet-Rich Plasma Prospective Studies Sensitivity and Specificity Transplantation, Autologous - methods Transplantation, Homologous - methods |
title | Comparison of the Efficacy of Homologous and Autologous Platelet-Rich Plasma (PRP) for Treating Androgenic Alopecia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T19%3A45%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20the%20Efficacy%20of%20Homologous%20and%20Autologous%20Platelet-Rich%20Plasma%20(PRP)%20for%20Treating%20Androgenic%20Alopecia&rft.jtitle=Aesthetic%20plastic%20surgery&rft.au=Ince,%20Bilsev&rft.date=2018-02-01&rft.volume=42&rft.issue=1&rft.spage=297&rft.epage=303&rft.pages=297-303&rft.issn=0364-216X&rft.eissn=1432-5241&rft_id=info:doi/10.1007/s00266-017-1004-y&rft_dat=%3Cproquest_cross%3E1993458789%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-1ef240061205c442dc5433919e0c0473ecedbb1101d588b6a85f5feed34ae6d23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1993458789&rft_id=info:pmid/29101437&rfr_iscdi=true |